Litcius/Paper detail

Bacterial Membrane Vesicles as a Novel Strategy for Extrusion of Antimicrobial Bismuth Drug in Helicobacter pylori

Sumith Kumar, Christine Schmitt, Olivier Gorgette, Martial Marbouty, Magalie Duchateau, Quentin Giai Gianetto, Mariette Matondo, Jean‐Michel Guigner, Hilde De Reuse

2022mBio20 citationsDOIOpen Access PDF

Abstract

Bacterial resistance to antibiotics is a major threat to human health. Treatments combining antibiotics with metals were proposed to circumvent this hurdle. Only one such combination is successfully used in clinics associating antibiotics with the metal bismuth to treat infections by the human pathogen Helicobacter pylori. H. pylori causes 800,000 deaths by gastric cancer yearly. How bismuth impacts H. pylori and its response to this toxic metal were ill defined. We discovered that upon bismuth exposure, H. pylori secretes membrane vesicles that are enriched in bismuth. Bismuth also induces the formation of intracellular polyphosphate granules associated with compaction of the chromosome. Upon bismuth exposure, H. pylori displays both defense and protection mechanisms, with bismuth extrusion by vesicles and shielding of the chromosome.

Topics & Concepts

BismuthHelicobacter pyloriMicrobiologyBacteriaChemistryNucleoidAntimicrobialBiologyBiochemistryEscherichia coliGeneGeneticsOrganic chemistryPneumocystis jirovecii pneumonia detection and treatmentSuperconductivity in MgB2 and AlloysPeptidase Inhibition and Analysis
Bacterial Membrane Vesicles as a Novel Strategy for Extrusion of Antimicrobial Bismuth Drug in Helicobacter pylori | Litcius